Utility of the EORTC risk tables and CUETO scoring model for predicting recurrence and progression in non-muscle-invasive bladder cancer patients treated with routine second transurethral resection

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

(2017) Marko Babjuk et al.   EUROPEAN UROLOGY

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in a United States Population

(2017) Kourosh Ravvaz et al.   JOURNAL OF UROLOGY

Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Guérin

(2015) Sümer Baltacı et al.   BJU INTERNATIONAL

External validation of European Organization for Research and Treatment of Cancer and Spanish Urological Club for Oncological Treatment scoring models to predict recurrence and progression in Japanese patients with non-muscle invasive bladder cancer treat

(2014) Yasuo Kohjimoto et al.   INTERNATIONAL JOURNAL OF UROLOGY

Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours

(2014) Moniek M. Vedder et al.   PLoS One

Clinical Value of Transurethral Second Resection of Bladder Tumor: Systematic Review

(2014) Jakub Dobruch et al.   UROLOGY

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder

(2013) E Xylinas et al.   BRITISH JOURNAL OF CANCER

Predicting Recurrence and Progression in Chinese Patients With Nonmuscle-invasive Bladder Cancer Using EORTC and CUETO Scoring Models

(2013) Tianyuan Xu et al.   UROLOGY

Epidemiology and Risk Factors of Urothelial Bladder Cancer

(2012) Maximilian Burger et al.   EUROPEAN UROLOGY

Role of Re-Resection in Non–Muscle-Invasive Bladder Cancer

(2011) Harry W. Herr   TheScientificWorldJOURNAL

Second Resection for Non-Muscle-Invasive Bladder Carcinoma: Current Role and Future Perspectives

(2010) Marko Babjuk   EUROPEAN UROLOGY

The Role of Tumor-Free Status in Repeat Resection Before Intravesical Bacillus Calmette-Guerin for High Grade Ta, T1 and CIS Bladder Cancer

(2010) Andrea Guevara et al.   JOURNAL OF UROLOGY

External validation and applicability of the EORTC risk tables for non-muscle-invasive bladder cancer

(2010) Virginia Hernández et al.   WORLD JOURNAL OF UROLOGY

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

(2009) Jesus Fernandez-Gomez et al.   JOURNAL OF UROLOGY

Safety of Active Surveillance Program for Recurrent Nonmuscle-invasive Bladder Carcinoma

(2009) V. Hernández et al.   UROLOGY

Economic aspects of bladder cancer: what are the benefits and costs?

(2009) K. D. Sievert et al.   WORLD JOURNAL OF UROLOGY